Abstract:ABSTRACT The emergence of antibiotic-resistant and biofilm-producing Staphylococcus aureus isolates presents major challenges for treating staphylococcal infections. Biofilm inhibition is an important anti-virulence strategy. In this study, a novel maleimide-diselenide hybrid compound (YH7) was synthesized and demonstrated remarkable antimicrobial activity against methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) in both planktonic cultures and biofilms. The minimum inhibitory concentration (MIC) of YH7 for S. aureus isolates was 16 μg/mL. Quantification of biofilms demonstrated that the sub-MIC (4 μg/mL) of YH7 significantly inhibits biofilm formation in both MSSA and MRSA. Confocal laser scanning microscopy analysis further confirmed the biofilm inhibitory potential of YH7. YH7 also significantly suppressed bacterial adherence to A549 cells. Moreover, YH7 treatment significantly inhibited S. aureus colonization in nasal tissue of mice. Preliminary mechanistic studies revealed that YH7 exerted potent biofilm-suppressing effects by inhibiting polysaccharide intercellular adhesin (PIA) synthesis, rather than suppressing bacterial autolysis. Real-time quantitative PCR data indicated that YH7 downregulated biofilm formation-related genes ( clfA , fnbA , icaA, and icaD ) and the global regulatory gene sarX , which promotes PIA synthesis. The sarX -dependent antibiofilm potential of YH7 was validated by constructing S. aureus NCTC8325 sarX knockout and complementation strains. Importantly, YH7 demonstrated a low potential to induce drug resistance in S. aureus and exhibited non-toxic to rabbit erythrocytes, A549, and BEAS-2B cells at antibacterial concentrations. In vivo toxicity assays conducted on Galleria mellonella further confirmed that YH7 is biocompatible. Overall, YH7 demonstrated potent antibiofilm activity supports its potential as an antimicrobial agent against S. aureus biofilm-related infections. IMPORTANCE Biofilm-associated infections, characterized by antibiotic resistance and persistence, present a formidable challenge in healthcare. Traditional antibacterial agents prove inadequate against biofilms. In this study, the novel compound YH7 demonstrates potent antibiofilm properties by impeding the adhesion and the polysaccharide intercellular adhesin production of Staphylococcus aureus . Notably, its exceptional efficacy against both methicillin-resistant and methicillin-susceptible strains highlights its broad applicability. This study highlights the potential of YH7 as a novel therapeutic agent to address the pressing issue of biofilm-driven infections.

Antimicrobial Activities of Yycg Histidine Kinase Inhibitors Against Staphylococcus Epidermidis Biofilms

Structure-based Discovery of Inhibitors of the YycG Histidine Kinase: New Chemical Leads to Combat Staphylococcus Epidermidis Infections

Efficacy of Novel Antibacterial Compounds Targeting Histidine Kinase YycG Protein

Anti-bacterial and Anti-biofilm Evaluation of Thiazolopyrimidinone Derivatives Targeting the Histidine Kinase YycG Protein of Staphylococcus Epidermidis.

Thiazolidione Derivatives Targeting the Histidine Kinase YycG Are Effective Against Both Planktonic and Biofilm-Associated Staphylococcus Epidermidis

Monoclonal Antibodies Specific to the Extracellular Domain of Histidine Kinase YycG of Staphylococcus Epidermidis Inhibit Biofilm Formation

Selection and Identification of Novel Antibacterial Agents Against Planktonic Growth and Biofilm Formation of Enterococcus Faecalis.

Antibacterial And Anti-Biofilm Activities Of Thiazolidione Derivatives Against Clinical Staphylococcus Strains

Organic Compounds Inhibiting S. Epidermidis Adhesion and Biofilm Formation

Effect of anti-YycG monoclonal antibody against Staphylococcus epidermidis biofilm formation

Antibacterial and Anti-Biofilm Activities of Histidine Kinase YycG Inhibitors Against Streptococcus Agalactiae

Biological Evaluation of Halogenated Thiazolo[3,2-A]pyrimidin-3-one Carboxylic Acid Derivatives Targeting the YycG Histidine Kinase.

Novel small-molecule compound YH7 inhibits the biofilm formation of Staphylococcus aureus in a sarX-dependent manner

The Antibacterial and Anti-biofilm Activities of Two Thiazolidione Derivatives (H2-60 and H2-81) Against Clinical Enterococcus Faecium Strains

Novel Fluorinated Pyrrolomycins As Potent Anti-Staphylococcal Biofilm Agents: Design, Synthesis, Pharmacokinetics and Antibacterial Activities.

Complex Analysis of Vanillin and Syringic Acid as Natural Antimicrobial Agents against Staphylococcus epidermidis Biofilms

Chromone Derivatives CM3a Potently Eradicate <i>Staphylococcus aureus</i> Biofilms by Inhibiting Cell Adherence

Synthesis and antibiofilm evaluation of N-acyl-2-aminopyrimidine derivatives against Acinetobacter baumannii

Strategies for Interfering with Bacterial Early Stage Biofilms

Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus.

Antibiofilm Activity of Small-Molecule ZY-214-4 Against Staphylococcus Aureus